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Abstract Literature about pacemaker (PM) implantations
shows that several clinical and technical factors determine
the short- and long-term complications after the intervention.
Annual hospital volume, however, does not negatively affect
complications in contrast with the cumulative experience of
the operator. In view of this observation, the current required
number of 20 to 30 first PM implantations for cardiology
training does not match standards for quality of care. In
addition, concentration of implants and replacement of pace-
makers to a limited number of operators per hospital to com-
ply with the increasing demands of patients and other parties
has to be seriously considered.
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Since 1959, pacemaker (PM) implantation exclusively for
bradycardia indications has become a routine procedure. Nu-
merous measures have been undertaken to ameliorate the
surgical procedure as well as the technical performance of
the implanted device. In the very early days epicardial leads
were only available requiring thoracotomy and therefore at
that time implantations were carried out in the operating
theatre by cardiac surgeons. However, when endocardial leads
became available, cardiologists took over the implantation
procedure and the catheterisation room, with its gradually
improving imaging techniques, replaced the operating theatre.
Early studies could not show any difference in complication
rates of first PM implantation, specifically regarding infection,
between the two facilities [1], and the costs of implantation in
the catheterisation room were clearly lower [2].
However, these observations should be envisaged with
caution due to the small sample size, retrospective study
design and generally short follow-up after first PM implanta-
tion. Focussing on the incidence of infection after first PM
implantation, the low prevalence (varying from 0.6 to 3 %,
[3–5] requires a considerable number of patients for a com-
parative study to obtain a clear answer on the best preventive
measures [6]. PM replacement, for whatever reason, is asso-
ciated with a remarkably higher complication rate [7], in
particular infection [8]. Cardiac device infections are serious,
sometimes life-threatening [9] and cause high additional hos-
pital costs [10], specifically due to the intensive and long-term
care. It is emphasised that a study of the outcome of PM
replacements comparing this intervention in the catheterisa-
tion room versus the operating theatre, has never been
published.
Nevertheless, a first PM implantation or replacement of the
electronic generator for whatever reason is today thought to be
an easy, safe and 1-day procedure that can be done in the
catheterisation room of all cardiology departments of the
Netherlands. This applies for single-chamber versus double-
chamber PM implantations [3]. Antibiotic prophylaxis plus
antiseptics within 1 h before the procedure greatly reduces
surgical infections [5, 6] and this measure contributes strongly
to the opinion about the ease of PM implantation or replace-
ment. It should be emphasised that PM treatment is associated
with a clearly lower complication rate and less adverse impact
on patient outcome [11] than ICD implantation with or with-
out a cardiac resynchronisation device, which requires a spe-
cial licence in our country,
Assessment of quality of care encompasses established
matters as the appropriateness, safety and cost-effectiveness
of a treatment and these components have become important
chapters in patient care and patient counselling. Regarding
safety of a PM implantation or replacement, reflected by the
type and number of complications, one can speculate about
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the relationship between the annual hospital volume of these
interventions and the number of immediate and late compli-
cations. The pre-implantation morbidity and technical com-
plexity of PM implantation strongly determine the acute and
late complication rates: a reduced left ventricular function, a
dilated right ventricle, heart failure and infection at the time of
first implantation, are predictors for an unfavourable outcome
[12]. Hospital volume is often thought to be of predictive
value but the Followpace study [4] could not observe any
relationship between early and late complication rate with the
annual hospital volume of 23 Dutch general and university
hospitals. Several other device studies underlined this out-
come [13, 14] and therefore hospital volume as such cannot
be considered an unfavourable determinant for complications.
Operator experience, defined as the cumulative number of
PM implantations or annual implantations per operator, ap-
pears more related to complications than the annual hospital
volume. Tobin et al. [15] indeed noted an inverse relationship
between the yearly number of cases per operator and compli-
cation rate (r =−0.90, p =0.002) and experience in terms of
years of PM implantation (r =0.81, p =0016): operators doing
>40 cases/year and/or >10 years of experience had the lowest
complication rates. Wiegand et al. [16] confirmed this obser-
vation within a study of anticoagulation or antiplatelet man-
agement in patients who underwent PM or ICD implantation.
Implanter experience was an independent predictor for pocket
bleeding as well as for the need for reoperation for this
complication: HR 0.61 for operators with >100 implantations
experience and HR 1.75 for those <50 ones. Eberhardt et al.
[12] defined three levels of cumulative experience, namely
<50, 50–100 and >100 PM implantations and observed obvi-
ously lower hazard ratios for operation and fluoroscopic time
and number of operative revisions in the group of operators
with largest experience. Furthermore, this study showed that
the complication rate of single- and dual-chamber PM implan-
tations was similar in experienced hands in contrast to inex-
perienced operators. The authors calculated a relative risk
reduction for complications of 0.6 % for each implanted PM
and concluded that ‘more than 100 PM implantations seem to
have been necessary to achieve a low complication rate’.
These data indicate that operator experience of PM implan-
tations clearly counts to promote quality of care. When cardi-
ology training in the Netherlands is considered (see paragraph
8.4.2010), a minimum of 20 or 30 first PM implantations for
competence level 1 and 2, respectively, is prescribed (April
2010: see www.nvvc.nl/opleiding). These numbers do not
suffice at all to comply with the above-mentioned observa-
tions of the necessity of a large operator experience [14, 17].
Furthermore, the April 2013 standards of the Netherlands
Rhythm Association and the Committee for Quality of Care
of the Netherlands Society of Cardiology require annually
50 PM implantations per hospital and 25 per operator (see
www.nvvc.nl/richtlijnen/indicatoren-en-normen). That
includes one PM implantation in the hospital per week or
two monthly implantations per operator. One can seriously
doubt whether these numbers will fulfil the requirements of
today’s proposed high(er) levels of care.
Concentration of PM implantations to a small number of
cardiology trainees appears unavoidable and requires adapta-
tion of the training curriculum to cope with surgical tech-
niques for device pocket, lead insertion and PM technology,
which is now carried out annually in over 10,000 Dutch
patients with a too slow heart rhythm. This point of view
should be extended to licensed cardiologists by assigning
‘hot shots’ who perform at least 50 first PM implantations
per year. This also holds for the implantation of
resynchronisation devices without ICD. This new scenario
of standards will undoubtedly promote better PM treatment
in a time of increasing comorbidity and frail and very old
patients [18] who are better informed than ever before. In
addition, less complications facilitate the nationwide applica-
tion of remote follow-up of PMs, which is unavoidable in the
coming years of budget constraints [19].
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